Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells
Figure 1
Efficacy of AdTRAIL in subcutaneous C4-2b xenografts. Male mice were subcutaneously injected with 2 million C4-2b cells. After tumor establishment, mice received three intratumoral injections of IU of AdGFP or AdTRAIL every 3 days (arrows). Data shown are from 6 tumors/group ().
